Literature DB >> 11690659

Clinical profile of arrhythmogenic right ventricular cardiomyopathy in Chinese patients.

W H Fung1, J E Sanderson.   

Abstract

OBJECTIVE: To study the clinical profile of Chinese patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). PATIENTS: Chinese patients who fulfilled the diagnostic criteria of ARVC proposed by the Task Force of the European Society of Cardiology and of the scientific council on cardiomyopathy of the International Society and Federation of Cardiology were recruited for analysis.
METHODS: Clinical data of patients with ARVC including age, sex, family history, presenting symptoms, electrocardiograph (ECG), echocardiography, cardiac catheterization, magnetic resonance imaging (MRI), electrophysiology study (EPS) and therapeutic intervention were analyzed.
RESULTS: Eleven patients (seven males) were diagnosed with ARVC. Mean age at clinical presentation was 42.6+/-14.8 years. Two patients (18.1%) had positive family history of ARVC or premature sudden cardiac death. The commonest presenting symptoms were palpitation (73%) and dizziness (46%). Spontaneous ventricular tachycardia (VT) was the presenting arrhythmia in 54% and 1 (9%) with ventricular fibrillation and cardiac arrest. Seven patients (64%) had the ECG abnormality as defined by the Task Force. Echocardiography showed right ventricular (RV) dilatation in five patients (46%) and all patients had normal left ventricular function. Nine patients (90%) had RV wall thinning or fibrofatty replacement on MRI examination. Inducible monomorphic VT was detected in four out of nine patients at EPS. All eight patients had normal coronary arteries and left ventriculogram but RV dilatation and global hypokinesia was seen in three patients. Implantable cardioverter defibrillators were implanted in five patients and two of them had shocks delivered during the follow-up period.
CONCLUSION: In this study, familial incidence of premature sudden death in patients with ARVC appears to be low and left ventricular involvement in affected individuals is uncommon. MRI is still the best investigation for ARVC.

Entities:  

Mesh:

Year:  2001        PMID: 11690659     DOI: 10.1016/s0167-5273(01)00519-8

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.

Authors:  Kang Yin; Ligang Ding; Yuqiu Li; Wei Hua
Journal:  Clin Cardiol       Date:  2017-01-31       Impact factor: 2.882

Review 2.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy: new avenues for diagnosis and treatment.

Authors:  E E van der Wall; M Bootsma; H J J Wellens; J J Bax; A de Roos; M J Schalij
Journal:  Neth Heart J       Date:  2003-01       Impact factor: 2.380

3.  Sudden death due to arrhythmogenic right ventricular cardiomyopathy: Two case reports.

Authors:  Xinshan Chen; Yigu Zhang; Guangxun Rao; Guangzhao Huang
Journal:  Front Med China       Date:  2007-07-01

4.  Clinical picture of arrhythmogenic right ventricular dysplasia / cardiomyopathy patients from Indian origin.

Authors:  Dvn Maithili; Pranathi Rao Pamuru; Khalid Mohiuddin; Sushant Remersu; Narasimhan Calambur; Sai Satish Oruganti; Pratibha Nallari
Journal:  Indian Pacing Electrophysiol J       Date:  2009-01-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.